Education and debate North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis

Other members of the guideline development and project groups are listed in the Appendix This guideline addresses the appropriate use of non-steroidal anti-inflammatory drugs in the primary care treatment of patients with joint pain believed to be caused by degenerative arthritis. It does not consider therapies other than drug treatment. General practitioners must use their professional knowledge and judgement when applying guideline recommendations to the management of individual patients. They should note the information, contraindications, interactions, and side effects contained in the British National Formulary.1 This is a summary of the full version of the guideline.2 In this article, the statements accompanied by categories of evidence (cited as Ia, Ib, IIa, IIb, III, and IV) and recommendations classified according to their strength (A, B, C, or D) are as described previously and are summarised in the box.3 ### Summary points The methods used to develop the guideline have been described previously.3Briefly, we searched the electronic databases Medline and Embase, using a combination of subject heading and free text terms aimed at locating systematic reviews, meta-analyses, randomised trials, quality of life studies, and economic studies. The search was backed up by the expert knowledge and experience of group members. ### Strength of recommendation

[1]  P. Garner,et al.  Systematic review of amodiaquine treatment in uncomplicated malaria , 1996, The Lancet.

[2]  S. Halstead,et al.  The International Clinical Epidemiology Network (INCLEN): a progress report. , 1991, Journal of clinical epidemiology.

[3]  Effective Health Care , 1999 .

[4]  P. Rochon,et al.  A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. , 1994, Archives of internal medicine.

[5]  J Glanville,et al.  Finding information on clinical effectiveness , 1998, BMJ.

[6]  R. Collins,et al.  WHICH ANTICONVULSANT FOR WOMEN WITH ECLAMPSIA - EVIDENCE FROM THE COLLABORATIVE ECLAMPSIA TRIAL , 1995 .

[7]  J. Biddulph Standard Treatment Regimens—A Personal Account of Papua New Guinea Experience , 1989, Tropical doctor.

[8]  A. D. de Craen,et al.  Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review , 1996, BMJ.

[9]  M. Koch,et al.  Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials. , 1996, Archives of internal medicine.

[10]  C. Bulpitt,et al.  Joint pain and quality of life; results of a randomised trial. , 1989, British journal of clinical pharmacology.

[11]  J. Mason,et al.  North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care , 1998, BMJ.

[12]  The Surfaxin-Lavage for Mas Trial Group Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial , 1995, The Lancet.

[13]  A. B. Prasad,et al.  British National Formulary , 1994 .

[14]  Cindy Farquhar,et al.  3 The Cochrane Library , 1996 .

[15]  J. Todd,et al.  Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial , 1995, The Lancet.

[16]  S. Gore,et al.  Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. , 1992, BMJ.

[17]  G. Tildesley,et al.  Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. , 1988, BMJ.

[18]  Andrew D Oxman,et al.  Closing the gap between research and practice : an overview of systematic reviews of interventions to promote the implementation of research findings , 2011 .

[19]  J. Quick,et al.  A strategy for promoting improved pharmaceutical use: the International Network for Rational Use of Drugs. , 1992, Social science & medicine.

[20]  G Bréart,et al.  From the Cochrane Library , 2000, Revue d'epidemiologie et de sante publique.

[21]  Dean T. Jamison,et al.  World development report 1993 : investing in health , 1993 .

[22]  P. Gøtzsche Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. , 1989, Controlled clinical trials.

[23]  M. Uplekar,et al.  Private doctors and tuberculosis control in India. , 1993, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[24]  R. Martorell,et al.  Effectiveness of vitamin A supplementation in the control of young child morbidity and mortality in developing countries. Revised ed. , 1993 .

[25]  S. Hill,et al.  Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis , 1996, BMJ.

[26]  F. Shann,et al.  Acute lower respiratory tract infections in children: possible criteria for selection of patients for antibiotic therapy and hospital admission. , 1984, Bulletin of the World Health Organization.

[27]  BOMBAY CALCUrIA,et al.  World development report 1993--investing in health. , 1993, Communicable disease report. CDR weekly.

[28]  K. Brandt,et al.  Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic. , 1992, The Journal of rheumatology.

[29]  I. Russell,et al.  Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. , 1993, Arthritis and rheumatism.

[30]  D. Morley,et al.  Growth monitoring , 2001, Lancet.

[31]  L. Levine,et al.  Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs. , 1993, Archives of internal medicine.

[32]  W. Y. Zhang,et al.  Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol , 1997, BMJ.

[33]  Jeffrey Aronson WHEN I USE A WORD.. , 1996 .

[34]  G. Lindmark,et al.  Randomised controlled trial of a reduced-visits programme of antenatal care in Harare, Zimbabwe , 1996, The Lancet.

[35]  J. Senior,et al.  Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs , 1995, Annals of Internal Medicine.